Skip to main content
Erschienen in: Osteoporosis International 12/2015

01.12.2015 | Original Article

Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older

verfasst von: H. A. Bischoff-Ferrari, J. E. Orav, J. A. Kanis, R. Rizzoli, M. Schlögl, H. B. Staehelin, W. C. Willett, B. Dawson-Hughes

Erschienen in: Osteoporosis International | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Summary

In this study, we compare the extent to which seven available definitions of sarcopenia and two related definitions predict the rate of falling. Our results suggest that the definitions of Baumgartner and Cruz-Jentoft best predict the rate of falls among sarcopenic versus non-sarcopenic community-dwelling seniors.

Introduction

The purpose of the study is to compare the extent to which seven available definitions of sarcopenia and two related definitions predict the prospective rate of falling.

Methods

We studied a cohort of 445 seniors (mean age 71 years, 45 % men) living in the community who were followed with a detailed fall assessment for 3 years. For comparing the rate of falls in sarcopenic versus non-sarcopenic individuals, we used multivariate Poisson regression analyses adjusting for gender and treatment (original intervention tested vitamin D plus calcium against placebo). Of the seven available definitions, three were based on low lean mass alone (Baumgartner, Delmonico 1 and 2) and four required both low muscle mass and decreased performance in a functional test (Fielding, Cruz-Jentoft, Morley, Muscaritoli). The two related definitions were based on low lean mass alone (Studenski 1) and low lean mass contributing to weakness (Studenski 2).

Results

Among 445 participants, 231 fell, sustaining 514 falls over the 3-year follow-up. The prospective rate of falls in sarcopenic versus non-sarcopenic individuals was best predicted by the Baumgartner definition based on low lean mass alone (RR = 1.54; 95 % CI 1.09–2.18) with 11 % prevalence of sarcopenia and the Cruz-Jentoft definition based on low lean mass plus decreased functional performance (RR = 1.82; 95 % CI 1.24–2.69) with 7.1 % prevalence of sarcopenia. Consistently, fall rate was non-significantly higher in sarcopenic versus non-sarcopenic individuals based on the definitions of Delmonico 1, Fielding, and Morley.

Conclusion

Among the definitions investigated, the Baumgartner definition and the Cruz-Jentoft definition had the highest validity for predicting the rate of falls.
Literatur
1.
Zurück zum Zitat Eberstadt N, Groth H. Europe’s coming demographic challenge: unlocking the value of health. American Enterprise Institute for Health Policy Research. 2007 Eberstadt N, Groth H. Europe’s coming demographic challenge: unlocking the value of health. American Enterprise Institute for Health Policy Research. 2007
4.
5.
Zurück zum Zitat Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52(1):80–85CrossRefPubMed Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52(1):80–85CrossRefPubMed
12.
Zurück zum Zitat Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156CrossRefPubMed Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156CrossRefPubMed
13.
Zurück zum Zitat van Kan Abellan G, Andre E, Bischoff Ferrari HA (2009) Carla task force on sarcopenia: propositions for clinical trials. J Nutr Health Aging 13(8):700–707CrossRef van Kan Abellan G, Andre E, Bischoff Ferrari HA (2009) Carla task force on sarcopenia: propositions for clinical trials. J Nutr Health Aging 13(8):700–707CrossRef
14.
Zurück zum Zitat Visser M (2009) Towards a definition of sarcopenia—results from epidemiologic studies. J Nutr Health Aging 13(8):713–716CrossRefPubMed Visser M (2009) Towards a definition of sarcopenia—results from epidemiologic studies. J Nutr Health Aging 13(8):713–716CrossRefPubMed
15.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423PubMedCentralCrossRefPubMed Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256CrossRefPubMed Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256CrossRefPubMed
17.
Zurück zum Zitat Morley JE, Abbatecola AM, Argiles JM et al (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12(6):403–409CrossRefPubMed Morley JE, Abbatecola AM, Argiles JM et al (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12(6):403–409CrossRefPubMed
18.
Zurück zum Zitat Vellas B, Pahor M, Manini T et al (2013) Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations. J Nutr Health Aging 17(7):612–618PubMedCentralCrossRefPubMed Vellas B, Pahor M, Manini T et al (2013) Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations. J Nutr Health Aging 17(7):612–618PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Studenski S (2009) What are the outcomes of treatment among patients with sarcopenia? J Nutr Health Aging 13(8):733–736CrossRefPubMed Studenski S (2009) What are the outcomes of treatment among patients with sarcopenia? J Nutr Health Aging 13(8):733–736CrossRefPubMed
20.
Zurück zum Zitat Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS (2001) Sarcopenia. J Lab Clin Med 137(4):231–243CrossRefPubMed Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS (2001) Sarcopenia. J Lab Clin Med 137(4):231–243CrossRefPubMed
21.
Zurück zum Zitat Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763CrossRefPubMed Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763CrossRefPubMed
22.
Zurück zum Zitat Delmonico MJ, Harris TB, Lee JS et al (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55(5):769–774CrossRefPubMed Delmonico MJ, Harris TB, Lee JS et al (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55(5):769–774CrossRefPubMed
23.
Zurück zum Zitat Delmonico MJ, Harris TB, Visser M et al (2009) Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90(6):1579–1585PubMedCentralCrossRefPubMed Delmonico MJ, Harris TB, Visser M et al (2009) Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90(6):1579–1585PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S–991SPubMed Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S–991SPubMed
25.
Zurück zum Zitat von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle 1(2):129–133CrossRef von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle 1(2):129–133CrossRef
26.
Zurück zum Zitat Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21(4):543–559PubMedCentralCrossRefPubMed Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21(4):543–559PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Muscaritoli M, Anker SD, Argiles J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29(2):154–159CrossRefPubMed Muscaritoli M, Anker SD, Argiles J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29(2):154–159CrossRefPubMed
28.
Zurück zum Zitat Stevens JA, Corso PS, Finkelstein EA, Miller TR (2006) The costs of fatal and nonfatal falls among older adults. Injur Prevent 12:290–295, 2006 CrossRef Stevens JA, Corso PS, Finkelstein EA, Miller TR (2006) The costs of fatal and nonfatal falls among older adults. Injur Prevent 12:290–295, 2006 CrossRef
29.
Zurück zum Zitat Tromp AM, Pluijm SM, Smit JH, Deeg DJ, Bouter LM, Lips P (2001) Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol 54(8):837–844CrossRefPubMed Tromp AM, Pluijm SM, Smit JH, Deeg DJ, Bouter LM, Lips P (2001) Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol 54(8):837–844CrossRefPubMed
30.
Zurück zum Zitat Tinetti ME, Williams CS (1997) Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 337(18):1279–1284CrossRefPubMed Tinetti ME, Williams CS (1997) Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 337(18):1279–1284CrossRefPubMed
31.
Zurück zum Zitat Sterling DA, O’Connor JA, Bonadies J (2001) Geriatric falls: injury severity is high and disproportionate to mechanism. J Trauma 50(1):116–119CrossRefPubMed Sterling DA, O’Connor JA, Bonadies J (2001) Geriatric falls: injury severity is high and disproportionate to mechanism. J Trauma 50(1):116–119CrossRefPubMed
32.
Zurück zum Zitat Englander F, Hodson TJ, Terregrossa RA (1996) Economic dimensions of slip and fall injuries. J Forensic Sci 41(5):733–746CrossRefPubMed Englander F, Hodson TJ, Terregrossa RA (1996) Economic dimensions of slip and fall injuries. J Forensic Sci 41(5):733–746CrossRefPubMed
33.
Zurück zum Zitat Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670–676CrossRefPubMed Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670–676CrossRefPubMed
34.
Zurück zum Zitat Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2006) Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 166(4):424–430PubMed Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2006) Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 166(4):424–430PubMed
35.
Zurück zum Zitat Buchner DM, Hornbrook MC, Kutner NG et al (1993) Development of the common data base for the FICSIT trials. J Am Geriatr Soc 41(3):297–308CrossRefPubMed Buchner DM, Hornbrook MC, Kutner NG et al (1993) Development of the common data base for the FICSIT trials. J Am Geriatr Soc 41(3):297–308CrossRefPubMed
36.
Zurück zum Zitat Preece MA, O’Riordan JL, Lawson DE, Kodicek E (1974) A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum. Clin Chim Acta 54(2):235–242CrossRefPubMed Preece MA, O’Riordan JL, Lawson DE, Kodicek E (1974) A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum. Clin Chim Acta 54(2):235–242CrossRefPubMed
37.
Zurück zum Zitat Gallagher D, Visser M, De Meersman RE et al (1997) Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83(1):229–239PubMed Gallagher D, Visser M, De Meersman RE et al (1997) Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83(1):229–239PubMed
38.
Zurück zum Zitat Pichard C, Kyle UG, Bracco D, Slosman DO, Morabia A, Schutz Y (2000) Reference values of fat-free and fat masses by bioelectrical impedance analysis in 3393 healthy subjects. Nutrition (Burbank, Los Angeles County, Calif) 16(4):245–254CrossRef Pichard C, Kyle UG, Bracco D, Slosman DO, Morabia A, Schutz Y (2000) Reference values of fat-free and fat masses by bioelectrical impedance analysis in 3393 healthy subjects. Nutrition (Burbank, Los Angeles County, Calif) 16(4):245–254CrossRef
39.
40.
Zurück zum Zitat Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896CrossRefPubMed Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896CrossRefPubMed
41.
Zurück zum Zitat Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69(5):547–558PubMedCentralCrossRefPubMed Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69(5):547–558PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Visser M, Deeg DJ, Lips P, Harris TB, Bouter LM (2000) Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 48(4):381–386CrossRefPubMed Visser M, Deeg DJ, Lips P, Harris TB, Bouter LM (2000) Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 48(4):381–386CrossRefPubMed
43.
Zurück zum Zitat Scott D, Hayes A, Sanders KM, Aitken D, Ebeling PR, Jones G (2014) Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporos Int 25(1):187–193CrossRefPubMed Scott D, Hayes A, Sanders KM, Aitken D, Ebeling PR, Jones G (2014) Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporos Int 25(1):187–193CrossRefPubMed
44.
Zurück zum Zitat Murphy RA, Ip EH, Zhang Q et al (2014) Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci 69(6):751–758PubMedCentralCrossRefPubMed Murphy RA, Ip EH, Zhang Q et al (2014) Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci 69(6):751–758PubMedCentralCrossRefPubMed
45.
Zurück zum Zitat Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Stud Group Osteop Int 4(6):368–381CrossRef Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Stud Group Osteop Int 4(6):368–381CrossRef
46.
Zurück zum Zitat Correa-de-Araujo R, Hadley E (2014) Skeletal muscle function deficit: a new terminology to embrace the evolving concepts of sarcopenia and age-related muscle dysfunction. J Gerontol A Biol Sci Med Sci 69(5):591–594PubMedCentralCrossRefPubMed Correa-de-Araujo R, Hadley E (2014) Skeletal muscle function deficit: a new terminology to embrace the evolving concepts of sarcopenia and age-related muscle dysfunction. J Gerontol A Biol Sci Med Sci 69(5):591–594PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Cummings SR, Nevitt MC, Kidd S (1988) Forgetting falls. The limited accuracy of recall of falls in the elderly. J Am Geriatr Soc 36(7):613–616CrossRefPubMed Cummings SR, Nevitt MC, Kidd S (1988) Forgetting falls. The limited accuracy of recall of falls in the elderly. J Am Geriatr Soc 36(7):613–616CrossRefPubMed
48.
Zurück zum Zitat Bischoff-Ferrari HA (2011) The role of falls in fracture prediction. Curr Osteoporos Rep 9(3):116–121CrossRefPubMed Bischoff-Ferrari HA (2011) The role of falls in fracture prediction. Curr Osteoporos Rep 9(3):116–121CrossRefPubMed
49.
Zurück zum Zitat Newman AB, Kupelian V, Visser M et al (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51(11):1602–1609CrossRefPubMed Newman AB, Kupelian V, Visser M et al (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51(11):1602–1609CrossRefPubMed
Metadaten
Titel
Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older
verfasst von
H. A. Bischoff-Ferrari
J. E. Orav
J. A. Kanis
R. Rizzoli
M. Schlögl
H. B. Staehelin
W. C. Willett
B. Dawson-Hughes
Publikationsdatum
01.12.2015
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 12/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3194-y

Weitere Artikel der Ausgabe 12/2015

Osteoporosis International 12/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.